This funding opportunity solicits cooperative agreement applications for implementation of investigator-initiated, single or multi-site, interventional clinical trials across all phases within NIAMS mission areas. It supports trial preparation activities such as establishing IRB, contracts, and staffing. Transition to trial execution depends on meeting phase 1 milestones. Trials must be hypothesis-driven and have potential for high clinical impact.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and other specified organizations including foreign institutions. Specific eligibility details are provided in the full announcement.
